The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Dominic Allocco

Showing 1-14 of 14 articles
A multicentre, randomised controlled clinical study of drug-coated balloons for the treatment of coronary in-stent restenosis
Hamm C, Dörr O, Woehrle J, Krackhardt F, Ince H, Zeus T, Berland J, Piot C, Roubille F, Schult I, Allocco D, Nef H
July 17, 2020 | 10.4244/EIJ-D-19-00051
Interventions for valvular disease
Final results from the REPRISE I study: five-year clinical outcomes with the repositionable and fully retrievable LOTUS valve system
Gooley R, Worthley S, Whitbourn R, Montarello J, Newcomb A, Allocco D, Meredith I
December 7, 2018 | 10.4244/EIJ-D-18-00664
Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent
Meredith I, Verheye S, Dubois C, Dens J, Farah B, Carrié D, Walsh S, Oldroyd K, Varenne O, El-Jack S, Moreno R, Christen T, Allocco D
April 20, 2018 | 10.4244/EIJ-D-17-00529
A randomised comparison of biodegradable polymer- and permanent polymer-coated platinum-chromium everolimus-eluting coronary stents in China: the EVOLVE China study
Han Y, Liu H, Yang Y, Zhang J, Xu K, Fu G, Su X, Jiang T, Pang W, Chen J, Yuan Z, Li H, Wang H, Hong T, Liu H, Sun F, Allocco D, Zhang M, Dawkins K
November 20, 2017 | 10.4244/EIJ-D-17-00271
Interventions for valvular disease
Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients
Meredith I, Dumonteil N, Blackman D, Tchétché D, Walters D, Hildick-Smith D, Manoharan G, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Feldman T, Allocco D, Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01024
Interventions for valvular disease
Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort
Dumonteil N, Meredith I, Blackman D, Tchétché D, Hildick-Smith D, Spence M, Walters D, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Houle V, Allocco D, Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01025
One-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVE)
Tamburino C, Capodanno D, Erglis A, Menown I, Horvath I, Moreno R, Gilbert T, Crowley J, Calabria P, Allocco D, Dawkins K
March 20, 2015 | 10.4244/EIJY15M01_01
Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study
Meredith I, Worthley S, Whitbourn R, Antonis P, Montarello J, Newcomb A, Lockwood S, Haratani N, Allocco D, Dawkins K
March 20, 2014 | 10.4244/EIJV9I11A216
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent
Meredith I, Verheye S, Weissman N, Barragan P, Scott D, Valdés Chávarri M, West N, Kelbæk H, Whitbourn R, Walters D, Kubica J, Thuesen L, Masotti M, Banning A, Sjogren I, Stables R, Allocco D, Dawkins K
July 26, 2013 | 10.4244/EIJV9I3A52
Boston Scientific Lotus valve
Meredith I, Hood K, Haratani N, Allocco D, Dawkins K
September 30, 2012 | 10.4244/EIJV8SQA12
Longitudinal stent deformation: quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomised controlled clinical trials
Kereiakes D, Popma J, Cannon L, Kandzari D, Kimmelstiel C, Meredith I, Teirstein P, Verheye S, Allocco D, Dawkins K, Stone G
June 27, 2012 | 10.4244/EIJV8I2A32
PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses
Meredith I, Whitbourn R, Scott D, El-Jack S, Zambahari R, Stone G, Teirstein P, Starzyk R, Allocco D, Dawkins K
May 17, 2011 | 10.4244/EIJV7I1A15
First human use of the TAXUS Petal paclitaxel-eluting bifurcation stent
Ormiston J, Lefèvre T, Grube E, Allocco D, Dawkins K
May 25, 2010
Carotid artery revascularisation in high-surgical-risk patients with the NexStent and the FilterWire EX/EZ: 3-year results from the CABERNET trial
Hopkins L, Myla S, Grube E, Eles G, Dave R, Jaff M, Allocco D
April 12, 2010

Latest news

NEW ISSUE
Radiation protection, ticagrelor monotherapy, the COMPARE-ABSORB trial, the BASILICA technique...
BASILICA technique procedure recorded from aortic and left ventricular
October 23, 2020
NEW
READ NOW: 15th EBC consensus on bifurcation
Just Accepted Article
October 21, 2020
EDitorial
Occupational radiation exposure in interventional cardiology – time for further action
Robert A. Byrne
October 23, 2020
JAA
This Week's JAA's: Impact of intervention strategies after failed TMVR, Invasive assessment of a myocardial bridge...
October 20, 2020
Guidance Papers
Guidelines, consensus & position papers
August 28, 2020
Editorial
Consolidating the BASILICA technique in TAVI patients at risk of coronary obstruction
Josep Rodés-Cabau
October 23, 2020
Spyral, Popular-Tavi, Sort out IX, Solve TAVI, and more
(Released thanks to the support of Biotronik)
September 30, 2020
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke